Haiping Jiang
First Affiliated Hospital of Zhejiang University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Haiping Jiang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:58 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05934331 · A LM-302 Combination With Other Anti-Tumor Therapies Phase ll StudyLaNova Medicines Zhejiang Co., Ltd. · recruiting · Malignant Neoplasms of Digestive Organs · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:58 UTC. The ranking covers the 200 most relevant of 863 PubMed records, and a shared surname and initials can bring in a namesake. All 863 on PubMed
- Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.N Engl J Med · 20173,900 citationsRCR 133.1
- 2,002 citationsRCR 73.0
- 609 citationsRCR 30.9
- 471 citationsRCR 19.2
- 392 citationsRCR 33.0
- Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.N Engl J Med · 2024332 citationsRCR 38.4
- 316 citationsRCR 19.8
- Long-term efficacy of a hepatitis E vaccine.N Engl J Med · 2015293 citationsRCR 10.9
- Single-dose oritavancin in the treatment of acute bacterial skin infections.N Engl J Med · 2014253 citationsRCR 9.7
- 251 citationsRCR 28.5